CA2478121A1 - Composition antibiotique - Google Patents
Composition antibiotique Download PDFInfo
- Publication number
- CA2478121A1 CA2478121A1 CA002478121A CA2478121A CA2478121A1 CA 2478121 A1 CA2478121 A1 CA 2478121A1 CA 002478121 A CA002478121 A CA 002478121A CA 2478121 A CA2478121 A CA 2478121A CA 2478121 A1 CA2478121 A1 CA 2478121A1
- Authority
- CA
- Canada
- Prior art keywords
- antibiotic
- product
- host
- dosage form
- dispersion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
L'invention concerne des produits antibiotiques conçus pour permettre l'administration d'au moins deux antibiotiques différents. Ces produits sont constitués d'au moins trois ou quatre formes de dosage présentant des profils de libération différents. Ces différents antibiotiques sont choisis dans le groupe comprenant des paires d'antibiotiques spécifiques.
Applications Claiming Priority (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/092,811 | 2002-03-07 | ||
US10/092,811 US6623758B2 (en) | 2000-02-24 | 2002-03-07 | Cephalosporin-metronidazole antibiotic composition |
US10/092,858 | 2002-03-07 | ||
US10/093,321 | 2002-03-07 | ||
US10/093,214 US6638532B2 (en) | 2000-02-24 | 2002-03-07 | Tetracycline—doxycycline antibiotic composition |
US10/092,854 | 2002-03-07 | ||
US10/093,321 US6610328B2 (en) | 2000-02-24 | 2002-03-07 | Amoxicillin-clarithromycin antibiotic composition |
US10/093,214 | 2002-03-07 | ||
US10/092,858 US6632453B2 (en) | 2000-02-24 | 2002-03-07 | Ciprofoxacin-metronidazole antibiotic composition |
US10/092,854 US6627222B2 (en) | 2000-02-24 | 2002-03-07 | Amoxicillin-dicloxacillin antibiotic composition |
PCT/US2003/007118 WO2003075852A2 (fr) | 2002-03-07 | 2003-03-07 | Composition antibiotique |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2478121A1 true CA2478121A1 (fr) | 2003-09-18 |
Family
ID=27808882
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002478121A Abandoned CA2478121A1 (fr) | 2002-03-07 | 2003-03-07 | Composition antibiotique |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1487414A4 (fr) |
JP (1) | JP2005526059A (fr) |
CA (1) | CA2478121A1 (fr) |
WO (1) | WO2003075852A2 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
US20020068078A1 (en) | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
AUPS167602A0 (en) * | 2002-04-12 | 2002-05-16 | F.H. Faulding & Co. Limited | An improved modified release preparation |
JP2008505124A (ja) * | 2004-07-02 | 2008-02-21 | アドバンシス ファーマスーティカル コーポレイション | パルス送達用錠剤 |
WO2006110807A1 (fr) * | 2005-04-12 | 2006-10-19 | Elan Pharma International Limited | Compositions a liberation controlee comportant une celphalosporine pour le traitement d'une infection bacterienne |
ES2429095T3 (es) | 2005-05-18 | 2013-11-13 | Da Volterra | Aporte colónico de adsorbentes |
US8048413B2 (en) | 2006-05-17 | 2011-11-01 | Helene Huguet | Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules |
SI2294012T1 (sl) * | 2008-05-07 | 2014-11-28 | Salix Pharmaceuticals, Ltd. | Dajanje ÄŤistila za ÄŤrevo in antibiotika za zdravljenje ÄŤrevesne bolezni |
US9119793B1 (en) | 2011-06-28 | 2015-09-01 | Medicis Pharmaceutical Corporation | Gastroretentive dosage forms for doxycycline |
US10842802B2 (en) | 2013-03-15 | 2020-11-24 | Medicis Pharmaceutical Corporation | Controlled release pharmaceutical dosage forms |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS601128A (ja) * | 1983-06-15 | 1985-01-07 | Shionogi & Co Ltd | 作用持続型セフアクロル製剤 |
JPS61210025A (ja) * | 1985-03-14 | 1986-09-18 | Teisan Seiyaku Kk | 安定化された抗生物質複合顆粒製剤 |
US4728512A (en) * | 1985-05-06 | 1988-03-01 | American Home Products Corporation | Formulations providing three distinct releases |
US4794001A (en) * | 1986-03-04 | 1988-12-27 | American Home Products Corporation | Formulations providing three distinct releases |
JPS63162619A (ja) * | 1986-12-25 | 1988-07-06 | Teisan Seiyaku Kk | 遅溶性顆粒及びそれを用いた持続性複合顆粒 |
NL8800223A (nl) * | 1987-04-21 | 1988-11-16 | Philips Nv | Systeem voor het registreren van een informatiesignaal, alsmede een registratiedrager en registratieinrichting voor toepassing in het systeem. |
US5326570A (en) * | 1991-07-23 | 1994-07-05 | Pharmavene, Inc. | Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine |
US5260068A (en) * | 1992-05-04 | 1993-11-09 | Anda Sr Pharmaceuticals Inc. | Multiparticulate pulsatile drug delivery system |
US5260069A (en) * | 1992-11-27 | 1993-11-09 | Anda Sr Pharmaceuticals Inc. | Pulsatile particles drug delivery system |
WO1996010996A1 (fr) * | 1993-07-21 | 1996-04-18 | The University Of Kentucky Research Foundation | Gelule a plusieurs compartiments assurant une liberation controlee |
DE19718012C1 (de) * | 1997-04-29 | 1998-10-08 | Jenapharm Gmbh | Verfahren zur Herstellung peroral anwendbarer fester Arzneiformen mit gesteuerter Wirkstoffabgabe |
US5840329A (en) * | 1997-05-15 | 1998-11-24 | Bioadvances Llc | Pulsatile drug delivery system |
AUPP437698A0 (en) * | 1998-06-30 | 1998-07-23 | Baumgart, Karl | Methods for treatment of coronary, carotid and other vascular disease |
US6384081B2 (en) * | 1998-10-09 | 2002-05-07 | Charles L. Berman | Treatment of diseases of the eye characterized by the formation of metalloproteinase |
US6565882B2 (en) * | 2000-02-24 | 2003-05-20 | Advancis Pharmaceutical Corp | Antibiotic composition with inhibitor |
US6544555B2 (en) * | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
CA2400818C (fr) * | 2000-02-24 | 2009-01-06 | Advancis Pharmaceutical Corporation | Compositions antibiotiques et antifongiques |
-
2003
- 2003-03-07 EP EP03714005A patent/EP1487414A4/fr not_active Withdrawn
- 2003-03-07 JP JP2003574128A patent/JP2005526059A/ja active Pending
- 2003-03-07 CA CA002478121A patent/CA2478121A1/fr not_active Abandoned
- 2003-03-07 WO PCT/US2003/007118 patent/WO2003075852A2/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
AU2003218024A1 (en) | 2003-09-22 |
EP1487414A2 (fr) | 2004-12-22 |
WO2003075852A2 (fr) | 2003-09-18 |
EP1487414A4 (fr) | 2007-12-12 |
WO2003075852A3 (fr) | 2004-07-15 |
JP2005526059A (ja) | 2005-09-02 |
AU2003218024B2 (en) | 2008-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6991807B2 (en) | Antibiotic composition | |
US6623757B2 (en) | Antibiotic composition | |
US6730320B2 (en) | Tetracycline antibiotic product, use and formulation thereof | |
US6638532B2 (en) | Tetracycline—doxycycline antibiotic composition | |
US6610328B2 (en) | Amoxicillin-clarithromycin antibiotic composition | |
US7122204B2 (en) | Antibiotic composition with inhibitor | |
US8889187B2 (en) | Once a day amoxicillin product comprising immediate and delayed release dosage forms | |
US6669948B2 (en) | Antibiotic product, use and formulation thereof | |
US6667057B2 (en) | Levofloxacin antibiotic product, use and formulation thereof | |
US6663891B2 (en) | Erythromyacin antibiotic product, use and formulation thereof | |
US6627222B2 (en) | Amoxicillin-dicloxacillin antibiotic composition | |
US6623758B2 (en) | Cephalosporin-metronidazole antibiotic composition | |
US6667042B2 (en) | Fluroquinilone antibiotic product, use and formulation thereof | |
CA2494015C (fr) | Produit antibiotique, utilisation et formulation associees | |
US6663890B2 (en) | Metronidazole antibiotic product, use and formulation thereof | |
AU2001239841A1 (en) | Antibiotic and antifungal compositions | |
US6632453B2 (en) | Ciprofoxacin-metronidazole antibiotic composition | |
CA2470016A1 (fr) | Produit antibiotique, son utilisation et sa formulation | |
CA2478121A1 (fr) | Composition antibiotique | |
AU2003218024C1 (en) | Antibiotic composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |